Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
Jamal Rana, Assistant Physician in Chief at The Permanente Medical Group, in Pleasanton, California, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Our another exciting paper, led by Iribarren, published in American Journal of Preventive Cardiology. Interplay between family history and polygenic risk for coronary heart disease (CHD).
Family history of heart disease is a recognized risk factor. However, it is considered to have low accuracy due to recall bias. Likely reason it is not part of the risk factor base risk calculators such as PREVENT.
Cohort comprised of 61,352 individuals from Kaiser Permanente with follow-up time of 14 years.
Individuals underwent polygenic risk scoring PRS (CARDIO inCode-Score CHD PRS, GENinCode Plc).
PRS and family history CHD were positively correlated, and both independently contribute to risk of incident CHD.
High PRS was associated with similar increased CHD risk in persons with and without family history CHD. A key finding of this study is therefore the fact that PRS adds to risk information among individuals with negative family history.
Hazard ratio, due to joint effect of positive family history CHD and high PRS was well above two.
These results have important clinical implications because relying solely on self-reported family history is insufficient to fully characterize the genetic contribution to CHD and thus the use of PRS could complement traditional risk algorithms particularly among subjects with no known family history of CHD.”
Title: Interplay between family history and polygenic risk for coronary heart disease: A cohort study among over 60 thousand individuals
Authors: Carlos Iribarren, Meng Lu, Roberto Elosua, Martha Gulati, Nathan D. Wong, Jamal S.Rana
Read the Full Article on American Journal of Preventive Cardiology.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis
-
Mar 6, 2026, 14:56Women’s Health at the Center of the 2025–2027 Global Public Affairs Agenda – ISTH
-
Mar 6, 2026, 14:44Haroun Gajraj: A Must-Have Atlas for Venous Duplex and Phlebology
-
Mar 6, 2026, 14:35Selma Turkovic: Announcing the New Date for the WBIT Webinar
-
Mar 6, 2026, 14:33Caitlin Raymond: Why Transfusion Medicine Should Be Looped in Early in Transfusion Reactions
-
Mar 6, 2026, 14:28Peter Kouides: Why Raising the Ferritin Cutoff in Women Matters
-
Mar 6, 2026, 12:45Gajendra Singh Sandhu: Essential Brain Health Tips to Prevent Stroke